FORTVITA Trademark

Trademark Overview

On Monday, September 30, 2024, a trademark application was filed for FORTVITA with the United States Patent and Trademark Office. The USPTO has given the FORTVITA trademark a serial number of 98778764. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, April 8, 2025. This trademark is owned by FORTVITA BIOLOGICS (SINGAPORE) PTE.LTD.. The FORTVITA trademark is filed in the Pharmaceutical Products category with the following description:

medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; vaccines; drugs for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; diagnostic preparations for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; pharmaceutical preparations, namely, ophthalmics; pharmaceutical preparations for the treatment of ophtha...
fortvita

General Information

Serial Number98778764
Word MarkFORTVITA
Filing DateMonday, September 30, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, April 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of the stylized word "FORTVITA" with a design element to the left featuring two overlapping abstract leaves forming a vertical stem.
Goods and Servicesmedicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; vaccines; drugs for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; diagnostic preparations for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; pharmaceutical preparations, namely, ophthalmics; pharmaceutical preparations for the treatment of ophthalmic diseases and conditions; None of the aforementioned goods relating to nutritional or dietary supplements
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 30, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFORTVITA BIOLOGICS (SINGAPORE) PTE.LTD.
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressSINGAPORE 189767
SG

Trademark Events

Event DateEvent Description
Monday, September 30, 2024NEW APPLICATION ENTERED
Friday, October 11, 2024TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, October 11, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, April 4, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, April 4, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 8, 2025SUSPENSION LETTER WRITTEN
Tuesday, April 8, 2025LETTER OF SUSPENSION E-MAILED
Tuesday, April 8, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, April 7, 2025ASSIGNED TO EXAMINER

Related Keywords

fortvita diseases treatment purposes preparations medical arthritis infectious rheumatoid cardiovascular autoimmune